Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs

Snezana Radivojev, Sarah Zellnitz, Amrit Paudel, Eleonore Froehlich

Research output: Contribution to journalReview articleResearchpeer-review

Abstract

Inhalation is the preferred route for the treatment of lung diseases. More recently, also formulations for systemic treatment have been developed. For efficient development of inhalation products it is necessary to identify a link between particle parameters and in vivo performance. Such a relation exists for oral drugs where dissolution and permeation across Caco-2 monolayers are correlated to in vivo absorption. By contrast, the only in vitro parameter with established link to absorption for inhalation is particle size. In vitro dissolution could be another important parameter because low solubility determines bioavailability of inhaled drugs. The review highlights the importance of dissolution for drug availability in general and lists important differences in dissolution testing of oral and inhaled formulations. Dissolution testing protocols are summarized with focus on the composition of the various fluids, which are used to mimic particle dissolution in the deep lung. Finally, a role of in silico modelling in identification of physiologically relevant dissolution fluids and in in vitro in vivo correlation is suggested.
LanguageEnglish
Pages45-56
Number of pages12
JournalInternational Journal of Pharmaceutics
Volume556
DOIs
StatusPublished - 10 Feb 2019

Fingerprint

Inhalation
Pharmaceutical Preparations
Particle Size
Computer Simulation
Solubility
Biological Availability
Lung Diseases
Lung
In Vitro Techniques
Drug Liberation

Keywords

  • In vitro dissolution
  • Oral inhalation
  • Simulated lung fluid
  • Dissolution testing
  • Inhalation treatment
  • PBPK modelling

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs. / Radivojev, Snezana; Zellnitz, Sarah; Paudel, Amrit; Froehlich, Eleonore .

In: International Journal of Pharmaceutics, Vol. 556, 10.02.2019, p. 45-56.

Research output: Contribution to journalReview articleResearchpeer-review

@article{e4e76f1ec5af4fd089f4cef96c1b55aa,
title = "Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs",
abstract = "Inhalation is the preferred route for the treatment of lung diseases. More recently, also formulations for systemic treatment have been developed. For efficient development of inhalation products it is necessary to identify a link between particle parameters and in vivo performance. Such a relation exists for oral drugs where dissolution and permeation across Caco-2 monolayers are correlated to in vivo absorption. By contrast, the only in vitro parameter with established link to absorption for inhalation is particle size. In vitro dissolution could be another important parameter because low solubility determines bioavailability of inhaled drugs. The review highlights the importance of dissolution for drug availability in general and lists important differences in dissolution testing of oral and inhaled formulations. Dissolution testing protocols are summarized with focus on the composition of the various fluids, which are used to mimic particle dissolution in the deep lung. Finally, a role of in silico modelling in identification of physiologically relevant dissolution fluids and in in vitro in vivo correlation is suggested.",
keywords = "In vitro dissolution, Oral inhalation, Simulated lung fluid, Dissolution testing, Inhalation treatment, PBPK modelling",
author = "Snezana Radivojev and Sarah Zellnitz and Amrit Paudel and Eleonore Froehlich",
year = "2019",
month = "2",
day = "10",
doi = "10.1016/j.ijpharm.2018.11.072",
language = "English",
volume = "556",
pages = "45--56",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs

AU - Radivojev, Snezana

AU - Zellnitz, Sarah

AU - Paudel, Amrit

AU - Froehlich, Eleonore

PY - 2019/2/10

Y1 - 2019/2/10

N2 - Inhalation is the preferred route for the treatment of lung diseases. More recently, also formulations for systemic treatment have been developed. For efficient development of inhalation products it is necessary to identify a link between particle parameters and in vivo performance. Such a relation exists for oral drugs where dissolution and permeation across Caco-2 monolayers are correlated to in vivo absorption. By contrast, the only in vitro parameter with established link to absorption for inhalation is particle size. In vitro dissolution could be another important parameter because low solubility determines bioavailability of inhaled drugs. The review highlights the importance of dissolution for drug availability in general and lists important differences in dissolution testing of oral and inhaled formulations. Dissolution testing protocols are summarized with focus on the composition of the various fluids, which are used to mimic particle dissolution in the deep lung. Finally, a role of in silico modelling in identification of physiologically relevant dissolution fluids and in in vitro in vivo correlation is suggested.

AB - Inhalation is the preferred route for the treatment of lung diseases. More recently, also formulations for systemic treatment have been developed. For efficient development of inhalation products it is necessary to identify a link between particle parameters and in vivo performance. Such a relation exists for oral drugs where dissolution and permeation across Caco-2 monolayers are correlated to in vivo absorption. By contrast, the only in vitro parameter with established link to absorption for inhalation is particle size. In vitro dissolution could be another important parameter because low solubility determines bioavailability of inhaled drugs. The review highlights the importance of dissolution for drug availability in general and lists important differences in dissolution testing of oral and inhaled formulations. Dissolution testing protocols are summarized with focus on the composition of the various fluids, which are used to mimic particle dissolution in the deep lung. Finally, a role of in silico modelling in identification of physiologically relevant dissolution fluids and in in vitro in vivo correlation is suggested.

KW - In vitro dissolution

KW - Oral inhalation

KW - Simulated lung fluid

KW - Dissolution testing

KW - Inhalation treatment

KW - PBPK modelling

UR - http://www.scopus.com/inward/record.url?scp=85058188693&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2018.11.072

DO - 10.1016/j.ijpharm.2018.11.072

M3 - Review article

VL - 556

SP - 45

EP - 56

JO - International Journal of Pharmaceutics

T2 - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

ER -